We are delighted to announce the public launch of our annual “New Products MBA” program that involves custom monthly case studies and 1:1 coaching. Previously by private request only, this program is designed for senior executives with responsibility for new product development or those involved with strategic decision making in this area.
How does the coaching program work?
This is an individual program and lasts for one year during which 10 monthly case studies are undertaken on topics selected by the participant. These could be on a tumor type, pathway, indication or topic related to drug development e.g. the science and commercial challenges around chimeric antigen receptors. Case study topics are typically focused around the sponsoring company portfolio to enable learnings to be applied.
Each case study includes a 10-15 page written paper with background, analysis, insights and key strategic questions. Additional material in the form of scientific papers to read and videos to watch is also provided. The commitment required is equivalent to undertaking an Executive MBA.
Following review of the case study and accompanying material, a 1 to 1.5 hour 1:1 coaching session takes place by telephone with Sally Church, PhD in which key learnings are discussed.
Importantly, the program does not discuss confidential or proprietary information, it is focused on helping participants ask the right questions, not making a key decision for them.
Why is a new products coaching program necessary?
In recent years, oncology has become a fast changing environment where it is increasingly important to be able to see the scientific connections between pathways and tumor types, understand the emerging impact of new competitors with novel mechanisms of action, as well as biomarkers and companion diagnostics, and be aware of the evolving landscape for next generation immunotherapies.
What do participants gain from this program?
The result of this coaching program will be an increased scientific understanding that enhances the ability to ask the right strategic questions of New Product Development and Brand Marketing teams and enable more in-depth strategic collaboration at the both the senior and middle management level.
What level of staff is this program aimed at?
This program was originally developed for a board level senior executive at a global pharmaceutical company. Based on its success we are making it publicly available in 2013 to a limited number of participants. We anticipate that it would benefit those at the Senior Director to Executive VP level who are involved with a range of oncology new products.
How much does this coaching program cost?
The program is comparable in cost to attending an Executive MBA, please contact us if you would like to learn more.